Cuban scientists announced that the island’s Soberana vaccine candidate had received authorization to begin phase three trials immediately.
A second vaccine Abdala would also begin phase three trials soon, scientists said.
While many developing countries have struggled to import vaccines, Cuba has focused on making their own as a way to raise money and instill national pride in the island’s bio-medical industry.
Two of the four Cuban vaccines candidates are named Soberana – Spanish for sovereignty. The remaining two are called Abdala, the name of a poem written by Cuban revolutionary icon Jose Marti, and Mambisa, referring to Cuban guerillas who fought a bloody war for freedom against the Spanish.
More than 85,000 Cubans would take part in the two final phases of the trials as the island’s state-run biomedical industry begins larger production of the vaccines. If approved for widescale use, Soberana and Abdala would be the first two vaccines developed in Latin America.
You can read more on Cuba’s vaccine trials here.